23andMe Lays Off 40% of Staff, Shuts Drug Development Business

HS 11/11/2024
Advertisements




The genetics company is closing a unit that was once seen as core to its future.



Source link

More Stories

Stocks making the biggest moves premarket: Super Micro Computer, GE Vernova, Rocket Lab and more

HS 22/07/2026

Kalshi launches election hub for prediction markets ahead of midterms

HS 22/07/2026

Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production

HS 21/07/2026

You may have missed

What it means for patients, drugmakers and prices

HS 22/07/2026

ZIM vs IND: Shreyas Iyer backs India to emerge stronger after 'rough patch' in England

HS 22/07/2026

BPCL posts Rs 3,962 crore Q1 loss as high crude prices squeeze fuel margins

HS 22/07/2026

Chase Experiences guide: Access event presales, discounts and preferred seating

HS 22/07/2026

Renting a yacht in the Mediterranean this summer just got cheaper

HS 22/07/2026